26
Views
23
CrossRef citations to date
0
Altmetric
Article

Suppression of β-Amyloid Precursor Protein Signaling into the Nucleus by Estrogens Mediated through Complex Formation between the Estrogen Receptor and Fe65

, , , , &
Pages 1321-1333 | Received 13 Jul 2006, Accepted 16 Nov 2006, Published online: 27 Mar 2023

REFERENCES

  • Alexaki, V. I., I. Charalampopoulos, M. Kampa, H. Vassalou, P. Theodoropoulos, E. N. Stathopoulos, A. Hatzoglou, A. Gravanis, and E. Castanas. 2004. Estrogen exerts neuroprotective effects via membrane estrogen receptors and rapid Akt/NOS activation. FASEB J. 18:1594–1596.
  • Baek, S. H., K. A. Ohgi, D. W. Rose, E. H. Koo, C. K. Glass, and M. G. Rosenfeld. 2002. Exchange of N-CoR corepressor and Tip60 coactivator complexes links gene expression by NF-kappaB and beta-amyloid precursor protein. Cell 110:55–67.
  • Brady, M. E., D. M. Ozanne, L. Gaughan, I. Waite, S. Cook, D. E. Neal, and C. N. Robson. 1999. Tip60 is a nuclear hormone receptor coactivator. J. Biol. Chem. 274:17599–17604.
  • Cao, X., and T. C. Sudhof. 2001. A transcriptionally active complex of APP with Fe65 and histone acetyltransferase Tip60. Science 293:115–120.
  • Chang, A., S. Cheang, and X. Espanel. 2000. Rsp5 WW domains interact directly with the carboxyl-terminal domain of RNA polymerase II. J. Biol. Chem. 275:20562–20571.
  • Chiueh, C., S. Lee, T. Andoh, and D. Murphy. 2003. Induction of antioxidative and antiapoptotic thioredoxin supports neuroprotective hypothesis of estrogen. Endocrine 21:27–31.
  • Dodart, J. C., C. Mathis, and A. Ungerer. 2000. The beta-amyloid precursor protein and its derivatives: from biology to learning and memory processes. Rev. Neurosci. 11:75–93.
  • Dong, J. T., W. B. Isaacs, J. C. Barrett, and J. T. Isaacs. 1997. Genomic organization of the human KAI1 metastasis-suppressor gene. Genomics 41:25–32.
  • Dubal, D. B., H. Zhu, J. Yu, S. W. Rau, P. J. Shughrue, I. Merchenthaler, M. S. Kindy, and P. M. Wise. 2001. Estrogen receptor alpha, not beta, is a critical link in estradiol-mediated protection against brain injury. Proc. Natl. Acad. Sci. USA 98:1952–1957.
  • Espeland, M. A., S. R. Rapp, S. A. Shumaker, R. Brunner, J. E. Manson, B. B. Sherwin, J. Hsia, K. L. Margolis, P. E. Hogan, R. Wallace, M. Dailey, R. Freeman, and J. Hays. 2004. Conjugated equine estrogens and global cognitive function in postmenopausal women. JAMA 291:2959–2968.
  • Evans, R. M. 1988. The steroid and thyroid receptor superfamily. Science 240:889–895.
  • Gavva, N. R., R. Gavva, K. Ermekova, M. Sudol, and C. K. J. Shen. 1997. Interaction of WW domains with hematopoietic transcription factor p45/NF-E2 and RNA polymerase II. J. Biol. Chem. 272:24105–24108.
  • Ghisletti, S., C. Meda, A. Maggi, and E. Vegeto. 2005. 17β-Estradiol inhibits inflammatory gene expression by controlling NF-κB intracellular localization. Mol. Cell. Biol. 25:2957–2968.
  • Goodenough, S., M. Schafer, and C. Behl. 2003. Estrogen-induced cell signalling in a cellular model of Alzheimer's disease. J. Steroid Biochem. Mol. Biol. 84:301–305.
  • Goodenough, S., D. Schleusner, C. Pietrzik, T. Skutella, and C. Behl. 2005. Glycogen synthase kinase 3beta links neuroprotection by 17beta-estradiol to key Alzheimer processes. Neuroscience 132:581–589.
  • Guibao, G., and R. B. Simerly. 1994. Hormonal regulation of opioid peptide neurons in the anteroventral periventricular nucleus. Horm. Behav. 28:503–511.
  • Hao, J., W. G. Janssen, Y. Tang, J. A. Roberts, H. McKay, B. Lasley, P. B. Allen, P. Greengard, P. R. Rapp, J. H. Kordower, P. R. Hof, and J. H. Morrison. 2003. Estrogen increases the number of spinophilin-immunoreactive spines in the hippocampus of young and aged female rhesus monkeys. J. Comp. Neurol. 465:540–550.
  • Henderson, V. W. 1997. The epidemiology of estrogen replacement therapy and Alzheimer's disease. Neurology 5(Suppl.):S27–S35.
  • Jankowsky, J. L., D. J. Fadale, J. Anderson, G. M. Xu, V. Gonzales, N. A. Jenkins, N. G. Copeland, M. K. Lee, L. H. Younkin, S. L. Wagner, S. G. Younkin, and D. R. Borchelt. 2004. Mutant presenilins specifically elevate the levels of the 42 residue beta-amyloid peptide in vivo: evidence for augmentation of a 42-specific gamma secretase. Hum. Mol. Genet. 13:159–170.
  • Kimberly, W. T., J. B. Zhang, S. Y. Guenette, and D. J. Selkoe. 2001. The intracellular domain of β-amyloid precursor protein is established by Fe65 and translocates to the nucleus in a notch-like manner. J. Biol. Chem. 276:40288–40292.
  • Kimura, A., and M. Horikoshi. 1998. Tip60 acetylates six lysines of a specific class in core histones in vitro. Genes Cells 3:789–800.
  • Kinoshita, A., C. M. Whelan, O. Berezovska, and B. T. Hyman. 2002. Direct visualization of the gamma secretase-generated carboxyl-terminal domain of the amyloid precursor protein: association with Fe65 and translocation to the nucleus. J. Neurochem. 82:839–847.
  • Klinge, C. M., S. C. Jernigan, K. A. Mattingly, K. E. Risinger, and J. Zhang. 2004. Estrogen response element-dependent regulation of transcriptional activation of estrogen receptors alpha and beta by coactivators and corepressors. J. Mol. Endocrinol. 33:387–410.
  • Ko, S. Y., S. C. Lin, K. W. Chang, Y. K. Wong, C. J. Liu, C. W. Chi, and T. Y. Liu. 2004. Increased expression of amyloid precursor protein in oral squamous cell carcinoma. Int. J. Cancer 111:727–732.
  • Koo, E. H., and S. L. Squazzo. 1994. Evidence that production and release of amyloid beta-protein involves the endocytic pathway. J. Biol. Chem. 269:17386–17389.
  • Lee, H., F. Jiang, J. Q. Wang, S. V. Nicosia, J. Yang, B. Su, and W. Bai. 2000. MEKK1 activation of human estrogen receptor alpha and stimulation of the agonistic activity of 4-hydroxytamoxifen in endometrial and ovarian cancer cells. Mol. Endocrinol. 14:1882–1896.
  • Lee, H., and W. Bai. 2002. Inhibition of estrogen receptor nuclear export by ligand-induced and p38-mediated receptor phosphorylation. Mol. Cell. Biol. 22:5835–5845.
  • Li, P., S. V. Nicosia, and W. Bai. 2001. Antagonism between PTEN/Mmac1/Tep-1 and androgen receptor in growth and apoptosis of prostate cancer cells. J. Biol. Chem. 276:20444–20450.
  • Li, P., H. Lee, S. Guo, T. G. Unterman, G. Jenster, and W. Bai. 2003. AKT-independent protection of prostate cancer cells from apoptosis mediated through complex formation between the androgen receptor and FKHR. Mol. Cell. Biol. 23:104–118.
  • Lonard, D. M., Z. Nawaz, C. L. Smith, and B. W. Malley. 2000. The 26S proteasome is required for estrogen receptor-alpha and coactivator turnover and for efficient estrogen receptor-alpha transactivation. Mol. Cell 5:939–948.
  • MacLusky, N. J. 2004. Estrogen and Alzheimer's disease: the apolipoprotein connection. Endocrinology 145:3062–3064.
  • Maecker, H. T., S. C. Todd, and S. Levy. 1997. The tetraspanin superfamily: molecular facilitators. FASEB J. 11:428–442.
  • Manthey, D., S. Heck, S. Engert, and C. Behl. 2001. Estrogen induces a rapid secretion of amyloid β precursor protein via the mitogen-activated protein kinase pathway. Eur. J. Biochem. 268:4285–4291.
  • McAllister, D., X. Merlo, and J. Lough. 2002. Characterization and expression of the mouse tat interactive protein 60 kD (TIP60) gene. Gene 289:169–176.
  • Nawaz, Z., D. M. Lonard, A. P. Dennis, C. L. Smith, and B. W. O'Malley. 1999. Proteasome-dependent degradation of the human estrogen receptor. Proc. Natl. Acad. Sci. USA 96:1858–1862.
  • Olesen, K. M., H. M. Jessen, C. J. Auger, and A. P. Auger. 2005. Dopaminergic activation of estrogen receptors in neonatal brain alters progestin receptor expression and juvenile social play behavior. Endocrinology 146:3705–3712.
  • Sabo, S. L., A. F. Ikin, J. D. Buxbaum, and P. Greengard. 2001. The Alzheimer amyloid precursor protein (APP) and FE65, an APP-binding protein, regulate cell movement. J. Cell Biol. 153:1403–1414.
  • Seabrook, G. R., D. W. Smith, B. J. Bowery, A. Easter, T. Reynolds, S. M. Fitzjohn, R. A. Morton, H. Zheng, G. R. Dawson, D. J. S. Sirinathsinghji, C. H. Davies, G. L. Collingridge, and R. G. Hill. 1999. Mechanisms contributing to the deficits in hippocampal synaptic plasticity in mice lacking amyloid precursor protein. Neuropharmacology 38:349–359.
  • Shinohara, T., T. Miki, N. Nishimura, H. Nokihara, H. Hamada, N. Mukaida, and S. Sone. 2001. Nuclear factor-κB-dependent expression of metastasis suppressor KAI1/CD82 gene in lung cancer cell lines expressing mutant p53. Cancer Res. 61:673–678.
  • Shumaker, S. A., C. Legault, L. Kuller, S. R. Rapp, L. Thal, D. S. Lane, H. Fillit, M. L. Stefanick, S. L. Hendrix, C. E. Lewis, K. Masaki, and L. H. Coker. 2004. Conjugated equine estrogens and incidence of probable dementia and mild cognitive impairment in postmenopausal women. JAMA 91:2947–2958.
  • Smith, C. L., O. M. Conneely, and B. M. O'Malley. 1993. Modulation of the ligand-independent activation of the human estrogen receptor α by hormone and antihormone. Proc. Natl. Acad. Sci. USA 90:6120–6124.
  • Sudol, M., K. Sliwa, and T. Russo. 2001. Functions of WW domains in the nucleus. FEBS Lett. 490:190–195.
  • Sudol, M., and T. Hunter. 2000. NeW wrinkles for an old domain. Cell 103:1001–1004.
  • Toran-Allerand, C. D. 1976. Sex steroids and the development of the newborn mouse hypothalamus and preoptic area in vitro: implication for sexual differentiation. Brain Res. 189:413–427.
  • Tsai, M. J., and B. W. O'Malley. 1994. Molecular mechanisms of action of steroid/thyroid receptor superfamily members. Annu. Rev. Biochem. 63:451–486.
  • Turgeon, J. L., D. P. McDonnell, K. A. Martin, and P. M. Wise. 2004. Hormone therapy: physiological complexity belies therapeutic simplicity. Science 304:1269–1273.
  • Tzukerman, M. T., A. Esty, D. Santiso-Mere, P. Danielian, M. G. Parker, R. B. Stein, J. W. Pike, and D. P. McDonnell. 1994. Human estrogen receptor transactivational capacity is determined by both cellular and promoter context and mediated by two functionally distinct intramolecular regions. Mol. Endocrinol. 8:21–30.
  • Waragai, M., C. H. Lammers, S. Takeuchi, I. Iamfuku, Y. Udagawa, I. Kanazawa, M. Kawabata, M. M. Mouradian, and H. Okazawa. 1999. PQBP-1, a novel polyglutamine tract-binding protein, inhibits transcription activation by Brn-2 and affects cell survival. Hum. Mol. Genet. 8:977–987.
  • Weis, K. E., K. Ekena, J. A. Thomas, G. Lazennec, and B. S. Katzenellenbogen. 1996. Constitutively active human estrogen receptors containing amino acid substitutions for tyrosine 537 in the receptor protein. Mol. Endocrinol. 10:1388–1398.
  • Wise, P. M. 2005. Estrogens and cerebrovascular stroke: what do animal models teach us? Ann. N. Y. Acad. Sci. 1052:225–232.
  • Woolley, C. S., and B. S. McEwen. 1992. Estradiol mediates fluctuation in hippocampal synapse density during the estrous cycle in the adult rat. J. Neurosci. 12:2549–2554.
  • Yagi, R., L. F. Chen, K. Shigesada, Y. Murakami, and Y. Ito. 1999. A WW domain-containing yes-associated protein (YAP) is a novel transcriptional co-activator. EMBO J. 18:2551–2562.
  • Yang, J., L. New, Y. Jiang, J. Han, and B. Su. 1998. Molecular cloning and characterization of a human protein kinase that specifically activates c-Jun N-terminal kinase. Gene 212:95–102.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.